FILING ANALYSIS · FRIDAY, OCTOBER 30

AbbVie Inc. ABBV — 8-K: Results of Operations and Financial Condition

positive

AbbVie reported strong Q3 results with a 10.3% increase in net revenues and a significant increase in adjusted diluted EPS, also raising its 2026 adjusted diluted EPS guidance range and announcing a 2027 dividend increase

The filing

8-K - AbbVie Inc. (0001551152) (Filer)

Read the filing on SEC EDGAR →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →
All analyses · Earnings today · Latest brief · Track record
© 2026 Dutchcode B.V. · Built by
Blinkof.ai verified — grade A+